MCCT umbilical cord stem cell technology can produce cells free from immune rejection. Through isolation, cells’ viability and functionality are guaranteed which allows the body to recover young and healthy. This technology is also featured with a low temperature of 196 ℃ preservation to allow cells with long-term activity, as well as simple collection process, no pain, no adverse effects on the mother and child.
The umbilical cord is rich of mesenchymal stem cells, which have the most similar characteristics with the embryonic stem cells of the youngest stem cells. It has strong differentiation and can be divided into many types of cells without immune rejection.
1.Umbilical cord stem cells have powerful ability to differentiate, can differentiate a variety of tissue cells;
2.Umbilical cord stem cells have the most similar characteristics with the embryonic stem cells of the youngest stem cells;
3.Rich number of cells, strong value-added ability, providing number of cells for repair and regeneration of tissue organ;
4.Have a unique immune regulation function, no immune rejection;
5.With a huge clinical value of medical applications, the best seed cells for cell therapy;
6.Quantity expansion of umbilical cord mesenchymal stem cells can be occurred in vitro;
No immune rejection
Chromosomes of pregnant women and fetals are different, neither does blood type. The reason why they can both be OK is due to special substances in umbilical cord.
The cross section of the umbilical cord is composed of two arteries and one vein. The gap between the arteries and veins is filled with umbilical cord-like tissue—wharton’s jelly. In wharton’s jelly, there is full of MHC class I molecules, which ensure no immune rejection between mother and child.
Umbilical cord stem cells are extracted from the Dayton’s glue, so injecting umbilical cord stem cells into any individuals does not occurr immune rejection.
Umbilical cord mesenchymal stem cells (MSCs) have a high differentiation potential and can be differentiated in multiple directions. It has broad clinical application prospect in tissue engineering such as bone, cartilage, muscle, tendon, ligament, nerve, liver, endothelium and myocardium. It has been reported that MSCs isolated from human umbilical cord are better than that of bone marrow MSCs in the cell content and proliferation ability. The immunogenicity is lower than that of bone marrow MSCs, and it has the advantages of convenient preparation and no ethical controversy. So it is getting more and more popular among scientists. The culture system of stem cells is mainly in the culture medium containing animal serum. What changes in the internal structure of stem cells grown in such an environment are not yet known.
The morphological, growth characteristics, cell cycle and immunophenotype of umbilical cord mesenchymal stem cells were studied. The aim of these studies is to establish an enrichment method of umbilical cord mesenchymal stem cells, and to provide a powerful theory for the establishment of umbilical cord mesenchymal stem cell bank and clinical application.
human umbilical cord cells